Surprisingly, the incubation of A172 cells with copper in presence of Ang60–68Cys_NP potentiated the inhibitory effect of the protein fragment on VEGF release, demonstrating the therapeutic potential of copper chelating agents against tumour progression. The gene discussed is VEGFA; the disease is neoplasm.